IBEX officer awarded 3,250 RSUs in stock grant

IBEX Ltd reported that Chief Sales and CS Officer Bruce Neil Dawson acquired 3,250 common shares through a grant of restricted stock units (RSUs) at a stated price of $0.00 per share.

Rhea-AI Filing Summary

IBEX Ltd reported that Chief Sales and CS Officer Bruce Neil Dawson acquired 3,250 common shares through a grant of restricted stock units (RSUs) at a stated price of $0.00 per share. These RSUs convert into one common share each as they vest over time.

According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting annually over the following three years, so long as he remains continuously employed on each vesting date. After this grant, he directly holds 80,284 common shares. On each vesting date, a portion of shares will automatically be withheld by IBEX to cover tax withholding obligations in a non-discretionary transaction.

Insider Trade Summary

Grant/Award: 3,250 shares

Grant/Award 1 txn

Insider Dawson Bruce Neil

Role Chief Sales and CS Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	3,250	$0.00	$0.00

Holdings After Transaction: Common Shares — 80,284 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for Bruce Neil Dawson?

IBEX reported that Chief Sales and CS Officer Bruce Neil Dawson received a grant of 3,250 restricted stock units. Each RSU represents a contingent right to one common share, subject to multi-year vesting and employment-continuation conditions.

How many IBEX (IBEX) shares did Bruce Neil Dawson hold after this Form 4 transaction?

After the RSU grant, Bruce Neil Dawson was reported to beneficially own 80,284 IBEX common shares directly. This figure reflects his holdings following the 3,250-share RSU award disclosed in the insider transaction filing.

What is the vesting schedule for Bruce Neil Dawson’s new IBEX (IBEX) RSUs?

The RSUs vest over four years: 25% on July 1, 2026, and 25% annually for the next three years. Vesting requires that he remain in continuous service with IBEX on each vesting date.

Does Bruce Neil Dawson pay cash for the 3,250 IBEX (IBEX) RSUs granted?

No cash payment is indicated; the RSUs were granted at a stated price of $0.00 per share. They represent a contingent right to receive common shares upon future vesting, rather than an open-market purchase.

How will taxes be handled on Bruce Neil Dawson’s IBEX (IBEX) RSU vesting?

On each vesting date, IBEX will automatically withhold a portion of the common shares to satisfy Bruce Neil Dawson’s tax withholding obligations. This occurs in a non-discretionary transaction specified in the award terms.

What type of security was involved in Bruce Neil Dawson’s IBEX (IBEX) Form 4?

The transaction involved common shares delivered via restricted stock units. Each RSU corresponds to one IBEX common share upon vesting, subject to the multi-year vesting schedule and continued-service requirements described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 05:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dawson Bruce Neil

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales and CS Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/26/2026		A		3,250(1)	A	$0(1)	80,284	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.